PT - JOURNAL ARTICLE AU - Zhang, Zhe AU - Wu, Shipo AU - Liu, Yawei AU - Li, Kailiang AU - Fan, Pengfei AU - Song, Xiaohong AU - Wang, Yudong AU - Zhao, Zhenghao AU - Zhang, Xianwei AU - Shang, Jin AU - Zhang, Jinlong AU - Xu, Jinghan AU - Li, Yao AU - Li, Yaohui AU - Zhang, Jipeng AU - Fu, Kefan AU - Wang, Busen AU - Hao, Meng AU - Zhang, Guanying AU - Long, Pengwei AU - Qiu, Ziyu AU - Zhu, Tao AU - Liu, Shuling AU - Zhang, Yue AU - Shao, Fangze AU - Lv, Peng AU - Yang, Yilong AU - Zhao, Xiaofan AU - Sun, Yufa AU - Hou, Lihua AU - Chen, Wei TI - Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming AID - 10.1101/2022.03.08.22271816 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.08.22271816 4099 - http://medrxiv.org/content/early/2022/03/10/2022.03.08.22271816.short 4100 - http://medrxiv.org/content/early/2022/03/10/2022.03.08.22271816.full AB - The SARS-CoV-2 Omicron variant has become the dominant SARS-CoV-2 variant around the world and exhibits immune escape to current COVID-19 vaccines to some extent due to its numerous spike mutations. Here, we evaluated the immune responses to booster vaccination with intramuscular adenovirus-vectored vaccine (Ad5-nCoV), aerosolized Ad5-nCoV, a recombinant protein subunit vaccine (ZF2001) or homologous inactivated vaccine (CoronaVac) in those who received two doses of inactivated COVID-19 vaccines 6 months prior. We found that the Ad5-nCoV booster induced potent neutralizing activity against the wild-type virus and Omicron variant, while aerosolized Ad5-nCoV generated the greatest neutralizing antibody responses against the Omicron variant at day 28 after booster vaccination, at 14.1-fold that of CoronaVac, 5.6-fold that of ZF2001 and 2.0-fold that of intramuscular Ad5-nCoV. Similarly, the aerosolized Ad5-nCoV booster produced the greatest IFNγ T-cell response at day 14 after booster vaccination. The IFNγ T-cell response to aerosolized Ad5-nCoV was 12.8-fold for CoronaVac, 16.5-fold for ZF2001, and 5.0-fold for intramuscular Ad5-nCoV. Aerosolized Ad5-nCoV booster also produced the greatest spike-specific B cell response. Our findings suggest that inactivated vaccine recipients should consider adenovirus-vectored vaccine boosters in China and that aerosolized Ad5-nCoV may provide a more efficient alternative in response to the spread of the Omicron variant.Competing Interest StatementTao Zhu is the employee of CanSino Biologics and has stock options in CanSino Biologics. All other authors declare no competing interests.Clinical TrialChiCTR2200057278Funding StatementThis study was funded by the National Key R&D Program of ChinaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of 305 Hospital of PLA gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyoline (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors